- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on AdvAdvanced Solid Tumors in New Zealand
Total 3362 results
-
Zai Lab (Hong Kong), Ltd.Merck Sharp & Dohme LLC; Zai Biopharmaceutical (Shanghai) Co., Ltd.RecruitingMalignant Solid TumorUnited States, Spain, China
-
Genentech, Inc.RecruitingSolid TumorsKorea, Republic of, Netherlands, Spain, United States, Brazil, Canada, Italy, Australia, Belgium
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Montclair State UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMelanoma | Solid Tumor | Metastatic Melanoma | NeoplasmUnited States, United Kingdom
-
LaNova Australia Pty LimitedRecruitingAdvanced Solid TumorAustralia
-
Genentech, Inc.CompletedSolid TumorUnited States, Korea, Republic of, Spain, France
-
ImaginAb, Inc.CompletedMetastatic Solid Tumors | Positron-Emission TomographyUnited States
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
Memorial Sloan Kettering Cancer CenterTesaro, Inc.RecruitingSolid Tumor | Solid Tumor, Adult | Rectal Adenocarcinoma | Clinical Stage: Stage II (T3-4, N-) | Stage III (Any T, N+)United States
-
Leap Therapeutics, Inc.Completed
-
OBI Pharma, IncTerminatedLocally Advanced Solid TumorUnited States
-
Eli Lilly and CompanyTerminatedSolid TumorBelgium, United States, Japan
-
Columbia UniversityGenentech, Inc.RecruitingAdvanced Solid Tumor | Immune-related Adverse EventsUnited States
-
Y-mAbs TherapeuticsTerminatedOsteosarcoma | Neuroblastoma | Other Solid Tumor CancersUnited States
-
Avenzo Therapeutics, Inc.Recruiting
-
Centessa Pharmaceuticals (UK) LimitedLockBody Therapeutics LtdRecruitingAdvanced Solid TumorUnited States, France
-
CStone PharmaceuticalsCompleted
-
Xilio Development, Inc.Recruiting
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
R-PharmNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Yale UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Turning Point Therapeutics, Inc.RecruitingLymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS TumorsUnited States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
-
Indaptus Therapeutics, IncTranslational Drug DevelopmentRecruiting
-
Agenus Inc.Active, not recruiting
-
Novartis PharmaceuticalsActive, not recruiting
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNSCLC | Solid TumorUnited States
-
Xilio Development, Inc.Active, not recruiting
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Debiopharm International SACompletedSolid TumorUnited States, Spain, France
-
Zai Biopharmaceutical (Suzhou) Co., Ltd.Completed
-
AbbottTerminatedAdvanced or Metastatic Solid TumorsUnited States
-
BeiGeneSpringWorks Therapeutics, Inc.RecruitingSolid Tumor, AdultAustralia, United States
-
Australian & New Zealand Children's Haematology...National Health and Medical Research Council, Australia; Secura Bio, Inc.TerminatedRhabdoid Tumor | Atypical Teratoid/Rhabdoid Tumor | Malignant Rhabdoid Tumor | Recurrent Brain Tumor, ChildhoodAustralia, New Zealand, United States
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Effector TherapeuticsRecruitingSolid Tumor, AdultUnited States
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Synnovation Therapeutics, Inc.Recruiting
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States